News - Ten Bio

The origins of TenSkin™

Entering our third year since spin out, it’s time to celebrate the origins of our technology which has brought Ten Bio early success in a range of markets. The origin of our invention story stems from Robyn Hickerson, our co-founder and CEO, and her work at the University of Dundee. In the course of her research on the development of therapeutics for rare skin diseases, Robyn utilized various skin models. These included animal, cell-based and ex vivo models, but all…

‘When I was two, I was nearly new’ ….

‘When I was two I was nearly new’ … with thanks to A. A. Milne for the line from his 1927 poem ‘Now we are Six’.Ten Bio is not six, but we are two and ‘nearly new’ and celebrate the second anniversary of our launch in September this year. It has been a fascinating journey so far and with much more to come. I am very much looking forward to the success we will achieve on the journey to .…

Our differentiation in wound management….

Our differentiation in wound management….a note from the Chair. In the previous note from the chairman I emphasized the potential role for Ten Bio in the area of wound management. My reason for that emphasis is simple: if you are evaluating how well a new approach / treatment can influence wound healing, then the key attribute of the test platform must be that it exhibits human skin’s normal response to wounding in vivo . . . or as close to…

Dr Paul Campbell seconded to Ten Bio through UK Medical Research Council Innovation Scholarship

Dr Paul Campbell, Reader in Physics at the University of Dundee has recently begun a secondment to Ten Bio through an Innovation Scholarship funded by the UK’s Medical Research Council.

Proud to be presenting at the Society for Investigative Dermatology Annual Meeting in Portland

May 18-21, 2022 We are proud to be exhibiting and presenting at the Society for Investigative Dermatology annual meeting later this week. Our Founder and CEO Robyn Hickerson will be describing how optimal tension in ex vivo skin models facilitates wound healing. Robyn who is co-inventor of Ten Bio’s tension-based ex vivo skin model and a group leader in the School of Life Sciences at the University of Dundee will be demonstrating how the application of an optimized tension to…

It’s just the start of Ten Bio’s journey…

A note from the Chair. I was introduced to Ten Bio’s founders in November 2019. I was immediately engaged by two things: firstly, the logic in support of the business proposition. When researching skin and how it reacts to challenges and treatments, surely you want to use a medium as close to living skin as can be achieved. And secondly the founders’ sheer enthusiasm for their technology and the differences that it could, even should, make to skin research. Animal…

Investment enables Ten Bio to establish new skin testing technology in USA

A near-£1 million investment will help University of Dundee spinout company Ten Bio Ltd to commercialise the human skin culture system it developed to provide a viable alternative for many experiments currently performed on animals. Led by TRICAPITAL LTD and with matched funding from Scottish Enterprise, the investment of £911,000 will enable the company to progress its mission to transform the testing of new pharmaceutical and cosmetic products. Initial launch of the company’s brand will be in the US, where…

TenSkin used to show effects of filtered far-UVC radiation in skin

Ten Bio’s innovative human skin model, TenSkinTM, features in a recent publication assessing the carcinogenic risk through direct DNA damage of filtered far-UVC exposure. This work forms part of a concerted effort to evaluate the potential for full‐room inactivation of airborne SARS‐CoV‐2, the virus responsible for the COVID‐19 pandemic, using novel light sources, with an end goal of achieving rapid decontamination of occupied public spaces. This letter is published in the British Journal of Dermatology and is now available online…

Ten Bio win at Scottish Edge

Ten Bio win at Scottish Edge Ten Bio Ltd has won £65,000 in a national competition supporting Scotland’s most exciting new enterprises. Scottish EDGE is the UK’s largest business funding competition, supporting Scotland’s most innovative, high-growth potential start-up businesses. This year, Scottish EDGE received a record-breaking 327 applications. Ten Bio was one of three businesses to receive an IBioIC supported EDGE Award, a new addition to the Scottish EDGE competition partially funded by The Industrial Biotechnology Innovation Centre (IBioIC). A…

Converge Challenge prize for Ten Bio

Converge Challenge prize for Ten Bio Dr Hickerson was last night named runner-up in the Converge Challenge category of Converge 2020, receiving £29,000 in cash and in-kind business support. Converge is a company creation programme designed for staff, students and recent graduates across all Scottish universities.